Here is a well-organized, evidence-based summary of UGI endoscopy timing in acute variceal bleeding:
UGI Endoscopy Timing in Acute Variceal Bleeding
Pre-Endoscopy Stabilization (Do Before Scoping)
Before endoscopy, the following should be initiated as soon as possible:
- Vasoactive agents - Octreotide (50-100 mcg IV bolus, then 25-50 mcg/h infusion) or terlipressin; reduces portal pressure, controls active bleeding, and improves endoscopic yield. Continue for 3-5 days if varices confirmed.
- Prophylactic antibiotics - Third-generation cephalosporins (ceftriaxone 1 g IV) or fluoroquinolones (ciprofloxacin 400 mg IV). Reduces bacterial infections, rebleeding, and all-cause mortality in cirrhotic patients.
- Resuscitation - Blood transfusion to maintain Hb ~7-8 g/dL (restrictive strategy); avoid over-transfusion which raises portal pressure.
- Airway protection - Elective endotracheal intubation if massive bleeding, obtunded patient, or encephalopathy.
- Erythromycin/metoclopramide (promotility agents) - Consider 250 mg erythromycin IV 30-90 min before scope to clear blood from stomach and improve visualization.
Endoscopy Timing
| Clinical Situation | Recommended Timing |
|---|
| Unstable patient (after resuscitation) | Within 6-24 hours |
| Stable patient | Within 12-36 hours |
| General guideline (most sources) | Within 12-24 hours of presentation |
| Active/uncontrolled bleeding at presentation | As soon as hemodynamically safe |
Key principle: Endoscopy should be performed early, but only after adequate resuscitation and vasoactive drug initiation - not as the first intervention.
- The Washington Manual of Medical Therapeutics: "Therapeutic endoscopy should be performed early in acute upper GI bleeding (within 12-24 hours)."
- Tintinalli's Emergency Medicine: "Early endoscopy within 6-24 hours of presentation for unstable patients if adequately resuscitated and 12-36 hours for stable patients."
- Current Surgical Therapy: Primary treatment is medical (octreotide) followed by endoscopic management.
Endoscopic Treatment Options
- Endoscopic variceal ligation (EVL/banding) - Treatment of choice for esophageal varices. Fewer sessions needed and fewer complications vs. sclerotherapy.
- Injection sclerotherapy - Alternative if banding unavailable.
- Gastric varices - Sclerotherapy, band ligation, glue (N-butyl cyanoacrylate) injection, or thrombin injection. EVL is less effective for gastric than esophageal varices.
What If Endoscopy Fails?
Salvage / Rescue Options
- Balloon tamponade (Sengstaken-Blakemore tube) - Effective short-term bridge while arranging definitive therapy. Not a permanent solution due to rebleeding risk on deflation.
- Self-expanding esophageal metal stent - Alternative to balloon tamponade for refractory esophageal variceal bleeding.
- TIPS (Transjugular Intrahepatic Portosystemic Shunt) - Addresses underlying portal hypertension. Indicated when endoscopic + medical management fails.
Early/Preemptive TIPS
For high-risk patients (Child-Pugh class B with active bleeding at index endoscopy, or Child-Pugh class C with score <14), early TIPS within 72 hours (ideally <24 hours) of index endoscopy is indicated, as these patients have high rates of treatment failure with endoscopy alone.
2025 Meta-Analysis Update
A 2025 systematic review and meta-analysis (Luo et al.,
BMC Gastroenterology, PMID
40597728) found:
- No significant difference in overall mortality or rebleeding between "urgent" (<6 h) vs. "early" (6-24 h) endoscopy.
- Endoscopy within <6 hours was associated with higher mortality (OR 2.05, 95% CI 1.29-3.26, p=0.002) compared to the 6-24 hour window.
- Conclusion: Endoscopy timing within 24 hours should be individualized - rushing to scope before 6 hours does not improve outcomes and may be harmful.
Bottom line: The sweet spot for endoscopy in acute variceal bleeding is 6-24 hours after presentation, following resuscitation and vasoactive drug initiation. Scoping before 6 hours offers no benefit and may increase mortality; delaying beyond 24 hours is not recommended.
Sources: Washington Manual of Medical Therapeutics; Tintinalli's Emergency Medicine; Current Surgical Therapy 14e; Luo S et al., BMC Gastroenterol 2025 (PMID 40597728)